Concordia Healthcare Corp. T.CXR.R

RE:RE:RE:RE:RE:What Gouging?

[Pj1958]

Complete garbage again.... In that case no one should ever buy Apple Corp, because they price gauge their customer , by charging an exorbitant price for their products. They charge $ 850 for an iPhone that costs $ 30 to produce. Get a life , price increases that happen over a 3 year period prior to purchasing a company is not CXR responsibility . He can only be held accountable for price increases that are initiated by CXR.... End of story.

Lattice wrote: Pj:  Since WHEN you ask?  Since the time when a CEO would have been expected to do due diligence on the price history of AMCo drug portfolio before opening up his wallet to CInven?

In MT's defence, it also appears that Ackman didn't do his due diligence on his endorsement of Valeant's price gouging as evidenced by this gem at the Senate Committee last week:  "One of the things with due diligence is this industry is that its really really hard to find out prices for drugs," the guy from Harvard said after stuttering a bit.  I'm sure his clients were impressed to hear that.

(Source:  BusinessInsider.com/live Aril 27, 2016.  Bill Ackman and Valeant execs just got through one of the most brutel Senate hearings we've ever seen)  

Pj1958 wrote: LETTUCE.... Complete nonsense. Since when have companies been responsible for what happened prior to a purchase. Another short and distort attempt to hold CXR responsible for price hikes that happened 3 years before they purchased a product.

Lattice wrote: Stockcoach et al,  There is a significant discrepancy between the price you have stated for fusidic acid eyedrops compared to the price the Financial Times has reported.  The Financial Times showed an increase of 14X (Mike Hainsworth referred to it as 1400% increase on BNN yesterday) over a three year period from £2.09 to £29.06  
 
The pricing data was collected by RxSavings Solutions, a company that analyzes prescription costs for employers (rxsavingssolutions.com). This company can not be considered a short selling organization. 

The prices of branded medications are tightly controlled in the UK, but the neat thing about AMCo's niche products is that they are generic / off-patent drugs so these large price increases have slipped through the regulatory cracks.  

Furthermore, MT has gone on record in October 2015 for saying that his stock was unfairly tarred in a sector wide price gouging scandal.  In an interview on BNN, he flaunted his sustainable growth model driven by volume.  When the price increases on these drugs took place is not relevant -
Mr. Mark Thompson should have done his due diligence with regards to how much and when AMCo took price on products in a portfolio that he had just over-paid for.
 
Adamchess, I don't feel that your "short and distort" sacred utterance is justified on ths story. I do believe that this is just one more instance of a lack of transparency by the corporation CEO.  If my haters disagree with me that is fine, as the share price is always the final arbiter of variant viewpoints.

Scruggstyle wrote:

Stockcoach1 wrote:

Fucithalmic is an ophthalmic gel containing fusidic acid for the topical treatment of bacterial infections.

 

Concordia's Branded US prices- 10mg 5 gram tube $12.69 USD, without prescription $25.00 USD.

 

Concordia's Branded UK prices- 10mg 5 gram tube from £2.69-£6.92

 

 

Polysporin Eye and Ear drops in Canada around 10.00 - 17.00. 

Had Polysporin prescribed in the US and they cost me $96.00 USD over 10 years ago. 

 

Can't say that Concordia is gouging, they are not even close to the average prices. Don't forget this is a one time prescription, not something you need re-prescribed.

Even ordinary over the counter eye drops cost more than that.

Absolutely correct, thank you for the post!